Last updated on May 2019

Biological Dating of Cerebral Ischemia With GST- /PRDX1 to Detect Patients With Stroke of Unknown Onset Within the Therapeutic Window of Thrombolysis


Brief description of study

The FLAG1 study will assess the diagnostic performance of biomarkers Glutathion S-Transferase- (GST-) and Peroxyredoxin 1 (PRDX1) to identify cerebral infarction of less than 4,5 hours in a population of patients with neurological deficiency of less than 12 hours.

Clinical Study Identifier: NCT03364296

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.